Ozempic and Wegovy are two brand names for the same active ingredient, semaglutide, made by the same manufacturer. Since the molecule is identical, the meaningful differences are the FDA-approved indication each label carries and the maximum labeled dose: Ozempic for type 2 diabetes (up to 2 mg weekly), Wegovy for chronic weight management (up to 2.4 mg weekly).
Reviewed for accuracy · Last reviewed July 7, 2026As with other same-molecule pairs, Ozempic and Wegovy are not different drugs. Both are semaglutide, the same GLP-1 agonist from the same manufacturer, so the underlying mechanism and route are identical.
Two differences are worth naming. First, the FDA-approved indication: Ozempic is approved for type 2 diabetes, while Wegovy is approved for chronic weight management. Second, the maximum labeled dose differs, with Ozempic titrated up to 2 mg weekly and Wegovy up to 2.4 mg weekly. Wegovy's weight-management approval rests on the STEP 1 Phase 3 trial.
Because the active ingredient is shared, calling one stronger than the other is not accurate beyond the dose difference on each label. Which brand a person receives ties to the indication being treated, and that is a medical decision.
This page is an independent educational reference and is not medical advice. Talk to a doctor before starting or adjusting any compound.